The firm initiated coverage on Travere Therapeutics with an overweight rating and price target of $26, citing long-term growth potential.

Send your questions directly to Jim Cramer and his team of analysts at investingclubmailbag@cnbc.com.

U.S. lawmakers are seeking to review a licensing deal between Ford and China-based CATL involving a planned $3.5 billion battery cell plant in Michigan.

Ilya Lichtenstein and Heather Rhiannon Morgan are accused of trying to launder bitcoin stolen in the the 2016 hack of Bitfinex.

Early dating has a new challenge: The ubiquity of gratuity screens and changing expectations of when to tip and how much. Etiquette experts share advice.

Ark Invest’s Cathie Wood said her flagship innovation fund has reduced its China exposure to zero as the developing market faces an economic slowdown.

The Investing Club holds its “Morning Meeting” every weekday at 10:20 a.m. ET.

Deal activity is poised to rebound, and here are some of the potential candidates for the next wave of mergers and acquisitions, according to Goldman Sachs.

These are the stocks posting the largest moves in midday trading.

The U.S. central bank has indicated another increase in interest rates is coming as it tries to further ease inflation.